Alcentra Capital Corp (NASDAQ:ABDC) – Zacks Investment Research lowered their FY2017 earnings per share (EPS) estimates for Alcentra Capital Corp in a research report issued on Monday. Zacks Investment Research analyst L. Thompson now anticipates that the asset manager will post earnings of $1.48 per share for the year, down from their previous forecast of $1.57.
Several other equities analysts have also commented on ABDC. TheStreet upgraded shares of Alcentra Capital Corp from a “c” rating to a “b-” rating in a research report on Monday, April 3rd. Keefe, Bruyette & Woods assumed coverage on shares of Alcentra Capital Corp in a research report on Tuesday, April 11th. They set a “market perform” rating and a $14.00 price target for the company. Four investment analysts have rated the stock with a hold rating, The stock presently has a consensus rating of “Hold” and a consensus price target of $13.67.
TRADEMARK VIOLATION WARNING: This report was first published by Markets Daily and is owned by of Markets Daily. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://www.themarketsdaily.com/2017/05/20/fy2017-eps-estimates-for-alcentra-capital-corp-abdc-decreased-by-zacks-investment-research-updated.html.
Shares of Alcentra Capital Corp (NASDAQ:ABDC) opened at 14.4088 on Wednesday. The stock has a 50 day moving average of $14.03 and a 200 day moving average of $12.82. The firm has a market cap of $193.61 million, a PE ratio of 35.2293 and a beta of 0.79. Alcentra Capital Corp has a 1-year low of $11.00 and a 1-year high of $14.73.
Alcentra Capital Corp (NASDAQ:ABDC) last released its earnings results on Thursday, March 9th. The asset manager reported $0.45 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.35 by $0.10. Alcentra Capital Corp had a net margin of 4.74% and a return on equity of 10.88%. The company had revenue of $10.90 million during the quarter, compared to analysts’ expectations of $9.52 million.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 6th. Investors of record on Friday, June 30th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 9.54%. The ex-dividend date of this dividend is Wednesday, June 28th. Alcentra Capital Corp’s payout ratio is currently 1,046.23%.
Large investors have recently bought and sold shares of the company. Carnegie Capital Asset Management LLC bought a new stake in Alcentra Capital Corp during the third quarter valued at $222,000. Creative Planning increased its stake in Alcentra Capital Corp by 2.9% in the first quarter. Creative Planning now owns 20,570 shares of the asset manager’s stock valued at $283,000 after buying an additional 570 shares during the last quarter. Wells Fargo & Company MN increased its stake in Alcentra Capital Corp by 4.9% in the first quarter. Wells Fargo & Company MN now owns 28,835 shares of the asset manager’s stock valued at $396,000 after buying an additional 1,354 shares during the last quarter. Guggenheim Capital LLC increased its stake in Alcentra Capital Corp by 57.3% in the fourth quarter. Guggenheim Capital LLC now owns 67,654 shares of the asset manager’s stock valued at $810,000 after buying an additional 24,637 shares during the last quarter. Finally, Shelton Capital Management bought a new stake in Alcentra Capital Corp during the fourth quarter valued at $817,000. 42.09% of the stock is owned by institutional investors and hedge funds.
Alcentra Capital Corp Company Profile
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.
Receive News & Ratings for Alcentra Capital Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp and related companies with MarketBeat.com's FREE daily email newsletter.